Korro Bio (KRRO) Net Cash Flow (2018 - 2026)
Korro Bio (KRRO) posted Net Cash Flow of $39.9 million for Q1 2026, up 1758.27% on a QoQ basis from -$2.4 million in Q4 2025, and up 369.33% year-over-year from $8.5 million in Q1 2025.
Korro Bio (KRRO) Net Cash Flow (2018 - 2026) Analysis & Trends
Korro Bio's Net Cash Flow history runs 9 years deep, the most recent figure standing at $39.9 million for Q1 2026.
- Quarterly Net Cash Flow rose 369.33% year-over-year to $39.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (up 96.82% YoY) and the FY2025 annual result came in at -$33.9 million, up 70.3% from the prior year.
- Net Cash Flow was $39.9 million for Q1 2026 at Korro Bio, up from -$2.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $121.8 million in Q4 2023 and bottomed at -$49.4 million in Q2 2024.
- A 5-year average of -$1.1 million and a median of -$9.3 million in 2024 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 1897.37% in 2023, while the deepest fall reached 996.81% in 2023.
- Korro Bio's Net Cash Flow stood at -$6.8 million in 2022, then soared by 1897.37% to $121.8 million in 2023, then slumped by 107.66% to -$9.3 million in 2024, then surged by 74.21% to -$2.4 million in 2025, then surged by 1758.27% to $39.9 million in 2026.
- Business Quant data shows KRRO's Net Cash Flow at $39.9 million in Q1 2026, -$2.4 million in Q4 2025, and -$9.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 224.46 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 57.19 Mn |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | 39.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.90 Mn |
| Mar 31, 2026 | 39.90 Mn |
| Dec 31, 2025 | -2.41 Mn |
| Dec 31, 2025 | -2.41 Mn |
| Sep 30, 2025 | -9.46 Mn |
| Sep 30, 2025 | -9.46 Mn |
| Jun 30, 2025 | -30.52 Mn |
| Jun 30, 2025 | -30.52 Mn |
| Mar 31, 2025 | 8.50 Mn |
| Mar 31, 2025 | 8.50 Mn |
| Dec 31, 2024 | -9.33 Mn |
| Dec 31, 2024 | -9.33 Mn |
| Sep 30, 2024 | -27.95 Mn |
| Sep 30, 2024 | -27.95 Mn |
| Jun 30, 2024 | -49.43 Mn |
| Jun 30, 2024 | -49.43 Mn |
| Mar 31, 2024 | -27.36 Mn |
| Mar 31, 2024 | -27.36 Mn |
| Dec 31, 2023 | 121.83 Mn |
| Dec 31, 2023 | 121.83 Mn |